Kura Oncology Inc. (NASDAQ: KURA) is 11.60% higher on its value in year-to-date trading and has touched a low of $9.49 and a high of $19.93 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The KURA stock was last observed hovering at around $13.99 in the last trading session, with the day’s loss setting it -0.14% off its average median price target of $31.00 for the next 12 months. It is also 70.53% off the consensus price target high of $47.00 offered by 12 analysts, but current levels are 37.05% higher than the price target low of $22.00 for the same period.
Currently trading at $13.85, the stock is 17.36% and 17.74% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.07 million and changing -1.00% at the moment leaves the stock 3.80% off its SMA200. KURA registered 14.27% gain for a year compared to 6-month loss of -9.71%. The firm has a 200-day simple moving average (SMA200) of -$3.04.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
The stock witnessed a 36.72% gain in the last 1 month and extending the period to 3 months gives it a 18.38%, and is 12.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.91% over the week and 6.34% over the month.
Distance from 52-week low is 45.94% and -30.51% from its 52-week high.
Kura Oncology Inc. (KURA) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Kura Oncology Inc. (KURA) is a “Buy”. 12 analysts offering their recommendations for the stock have an average rating of 1.60, where 0 rate it as a Hold and 1 think it is a “Overweight”. 11 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Kura Oncology Inc. is expected to release its quarterly report on 08/03/2023.The EPS is expected to shrink by -3.10% this year
Kura Oncology Inc. (KURA) Top Institutional Holders
The shares outstanding are 68.40M, and float is at 64.56M with Short Float at 12.15%.
Kura Oncology Inc. (KURA) Insider Activity
A total of 9 insider transactions have happened at Kura Oncology Inc. (KURA) in the last six months, with sales accounting for 6 and purchases happening 3 times. The most recent transaction is an insider sale by DALE STEPHEN, the company’s Chief Medical Officer. SEC filings show that DALE STEPHEN sold 9,225 shares of the company’s common stock on Jan 27 at a price of $13.88 per share for a total of $0.13 million. Following the sale, the insider now owns 27675.0 shares.
Kura Oncology Inc. disclosed in a document filed with the SEC on Jan 27 that FLOWERS KIRSTEN (CCO & Chief Strategy Officer) sold a total of 1,906 shares of the company’s common stock. The trade occurred on Jan 27 and was made at $13.89 per share for $26474.0. Following the transaction, the insider now directly holds 20605.0 shares of the KURA stock.
Still, SEC filings show that on Jan 27, FORD KATHLEEN (Chief Operating Officer) disposed off 1,821 shares at an average price of $13.89 for $25294.0. The insider now directly holds 21,214 shares of Kura Oncology Inc. (KURA).
Kura Oncology Inc. (KURA): Who are the competitors?
The company’s main competitors (and peers) include Omeros Corporation (OMER) that is 114.23% higher over the past 12 months.
